Depakote extended release tablets offers patients the convenience of taking this medication once a day. When taken once-a-day, the extended release formulation of the drug helps provide more consistent levels of medication in the body. The maintenance of the level of medication in the body is an important factor in the treatment of mania.
“This expansion of the use of Depakote ER is another important step in Abbott’s commitment to developing innovative, effective and simpler treatments for neurological and psychological disorders,” said Dr Eugene Sun, vice president of global pharmaceutical clinical development at Abbott.
Approximately 2.3 million American adults have bipolar disorder, also known as manic-depressive illness. Bipolar disorder is a brain disorder that causes unusual shifts in a person’s mood, energy and ability to function.